advertisement

Topcon

Xue Y 11

Showing records 1 to 11 | Display all abstracts from Xue Y

124800 Antibiotic tolerance due to restriction of cAMP-Crp regulation by mannitol, a non-glucose-family PTS carbon source
Zhu W
mSphere 2024; 9: e0077224
123445 Forskolin is an effective therapeutic small molecule for the treatment of hypertrophic cardiomyopathy through ADCY6/cAMP/PKA pathway
Wang W
European Journal of Pharmacology 2024; 978: 176770
124800 Antibiotic tolerance due to restriction of cAMP-Crp regulation by mannitol, a non-glucose-family PTS carbon source
Chen M
mSphere 2024; 9: e0077224
123445 Forskolin is an effective therapeutic small molecule for the treatment of hypertrophic cardiomyopathy through ADCY6/cAMP/PKA pathway
Xue Y; Li D
European Journal of Pharmacology 2024; 978: 176770
124800 Antibiotic tolerance due to restriction of cAMP-Crp regulation by mannitol, a non-glucose-family PTS carbon source
Zhang X
mSphere 2024; 9: e0077224
123445 Forskolin is an effective therapeutic small molecule for the treatment of hypertrophic cardiomyopathy through ADCY6/cAMP/PKA pathway
Shao C
European Journal of Pharmacology 2024; 978: 176770
124800 Antibiotic tolerance due to restriction of cAMP-Crp regulation by mannitol, a non-glucose-family PTS carbon source
Su J
mSphere 2024; 9: e0077224
123445 Forskolin is an effective therapeutic small molecule for the treatment of hypertrophic cardiomyopathy through ADCY6/cAMP/PKA pathway
Wu K
European Journal of Pharmacology 2024; 978: 176770
124800 Antibiotic tolerance due to restriction of cAMP-Crp regulation by mannitol, a non-glucose-family PTS carbon source
Nong Y
mSphere 2024; 9: e0077224
123445 Forskolin is an effective therapeutic small molecule for the treatment of hypertrophic cardiomyopathy through ADCY6/cAMP/PKA pathway
Sun N; Chen Q
European Journal of Pharmacology 2024; 978: 176770
124800 Antibiotic tolerance due to restriction of cAMP-Crp regulation by mannitol, a non-glucose-family PTS carbon source
Wang B; Guo W; Xue Y; Wang D; Liao Y; Niu J; Niu J; Hong Y; Drlica K; Zhao X
mSphere 2024; 9: e0077224

Issue 25-1

Change Issue


advertisement

Topcon